Cargando…
Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathways
BACKGROUND: Nasopharyngeal carcinoma (NPC) is associated with Epstein–Barr virus (EBV) infection. To test preclinical NPC drugs, we established two patient-derived xenograft (PDX) mouse models, EBV-positive PDX-B13 and EBV-negative PDX-Li41, for drug screening. METHODS: Based on next generation sequ...
Autores principales: | Li, Hsin-Pai, Huang, Chen-Yang, Lui, Kar-Wai, Chao, Yin-Kai, Yeh, Chun-Nan, Lee, Li-Yu, Huang, Yenlin, Lin, Tung-Liang, Kuo, Yung-Chia, Huang, Mei-Yuan, Fan, Hsien-Chi, Lin, An-Chi, Hsieh, Chia-Hsun, Chang, Kai-Ping, Lin, Chien-Yu, Wang, Hung-Ming, Chao, Mei, Liu, Jai-Shin, Chang, Yu-Sun, Hsu, Cheng-Lung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509698/ https://www.ncbi.nlm.nih.gov/pubmed/37713975 http://dx.doi.org/10.1016/j.tranon.2023.101785 |
Ejemplares similares
-
Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinoma
por: Hsu, Cheng-Lung, et al.
Publicado: (2015) -
Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment
por: Li, Hsin-Pai, et al.
Publicado: (2021) -
Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma
por: Hsu, Cheng-Lung, et al.
Publicado: (2018) -
Correlation between overall survival and differential plasma and tissue tumor marker expression in nasopharyngeal carcinoma patients with different sites of organ metastasis
por: Wang, Hung-Ming, et al.
Publicado: (2016) -
Aberrantly hypermethylated Homeobox A2 derepresses metalloproteinase-9 through TBP and promotes invasion in Nasopharyngeal carcinoma
por: Li, Hsin-Pai, et al.
Publicado: (2013)